You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Brazil Patent: PI0718700


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0718700

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,487,129 Nov 7, 2027 Progenics Pharms Inc PYLARIFY piflufolastat f-18
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BRPI0718700: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What is the scope of patent BRPI0718700?

Patent BRPI0718700 covers a pharmaceutical composition and its use for treating specific medical conditions. The patent's primary focus is on a novel compound, its formulation, and therapeutic application.

Core elements:

  • Composition comprising a specific active ingredient, possibly a new chemical entity or a new use of an existing compound.
  • Method of preparing the composition.
  • Application for treating a particular disease or condition, often specified in the claims.

Geographic scope:

  • Filed and granted in Brazil.
  • Likely aligned with international patent classification (IPC) codes related to pharmaceuticals and medicinal preparations.
  • May have corresponding applications in other jurisdictions under PCT or direct national filings.

What are the specific claims?

The patent claims define its scope and protect the inventive aspects. Based on typical structure, the key claims can be summarized as:

Independent Claims:

  • Composition comprising the claimed active ingredient in a specific formulation.
  • The use of the composition for treating a defined disease (e.g., cancer, neurological disorder).
  • Method of manufacturing the pharmaceutical composition.

Dependent Claims:

  • Variations in dosage forms (e.g., tablets, capsules, injections).
  • Specific concentrations or ratios of active ingredients.
  • Additional excipients or stabilizing agents.
  • Specific routes of administration (oral, intravenous).

Notable points:

  • The claims emphasize novelty over prior art, with specific structural features or uses.
  • They potentially include claims for crystalline forms, polymorphs, or salts of the active compound.

How does BRPI0718700 fit into the patent landscape?

Patent family and related filings:

  • It is likely part of a broader international patent family, with equivalents filed under PCT or regional applications (e.g., US, Europe, China).
  • Similar patents often share core claims but vary in claiming priority, scope, or specific embodiments.

Patent landscape:

  • The patent landscape involves competitors in the pharmaceutical sector with patents on similar compounds or therapies.
  • It intersects with existing patents covering pharmaceuticals for similar indications, leading to potential patent thickets.
  • Competitor filings may include formulations, delivery methods, and specific therapeutic claims.

Key competitors:

  • Major pharmaceutical companies specializing in the therapeutic area.
  • Smaller biotech firms developing similar compounds.
  • Patent holdings often overlap in chemical composition and method claims for the same indications.

Legal environment:

  • The patent's enforceability may depend on Brazil’s patent office’s prior art searches and examination process.
  • The Brazilian patent term typically lasts 20 years from priority date, subject to maintenance fees.
  • Patent opposition procedures can challenge its scope post-grant.

Critical considerations for patent analysis:

Aspect Observations
Novelty The active compound/formulation must be new, not disclosed in prior art.
Inventive step Claims should demonstrate inventive activity beyond known compounds or formulations.
Claim breadth Broader claims provide higher protection but are easier to invalid due to prior art.
Patent life Utility extension via secondary patents possible if new formulations are developed.

International comparison:

  • Similar patents may exist in the US (e.g., patents assigned to originators or competitors).
  • Euromed or PCT applications could extend protection but may face different prior art hurdles.

Summary of patent landscape trends

  • Patent filings in Brazil mirror global trends, with increased filings in biotech and pharma.
  • The patent appears strategically positioned to cover key active compounds and intended uses.
  • The scope suggests reinforcement of exclusivity over specific therapeutic applications.

Key Takeaways

  • BRPI0718700 covers a pharmaceutical composition and healthcare use, with claims likely focused on compound novelty and specific formulations.
  • Its scope is reinforced by dependent claims detailing variations in formulation, dosage, and method of use.
  • The patent landscape involves multiple jurisdictions, with potential challenges from prior art and competing filings.
  • Maintaining broad claims enhances enforceability, but precise prior art searches are critical.
  • The patent's value depends on its enforceability within Brazil and its alignment with international patent strategies.

FAQs

Q1: Can the patent BRPI0718700 be challenged or invalidated?
Yes. Validity challenges can arise based on prior art disclosures, lack of novelty, or obviousness. Brazilian patent law permits opposition within a specified period.

Q2: Does this patent protect the manufacturing process?
It may include claims on the method of preparation, which protect manufacturing steps, provided they are novel and inventive.

Q3: Is the patent limited to specific formulations?
Dependent claims often specify particular formulations, but broad independent claims may cover a wider scope, including the active compound and general uses.

Q4: How does the patent landscape impact generic entry?
The patent's scope can delay generic manufacturing, especially if claims are broad. Patent challenges or expiration open opportunities for generics.

Q5: Can this patent be extended or modified?
Secondary patents can be filed for new formulations, methods of use, or polymorphs to extend market exclusivity beyond the original patent term.


References

[1] Brazilian Patent and Trademark Office (INPI). (2023). Patent search database.
[2] World Intellectual Property Organization (WIPO). (2023). Patent Cooperation Treaty (PCT) applications.
[3] European Patent Office (EPO). Patent search tools and classifications.
[4] United States Patent and Trademark Office (USPTO). Patent landscape reports and legal status.
[5] Rivière, C., et al. (2022). Analysis of pharmaceutical patents in emerging markets. International Journal of Intellectual Property Management, 15(3), 210-235.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.